Previous studies have shown that neuroinflammation could be attenuated by IGF1R inhibition in an experimental autoimmune encephalomyelitis model of multiple sclerosis [26] or Alzheimer’s disease [58–60]. The gene discussed is IGF1R; the disease is early-onset autosomal dominant Alzheimer disease.